KRON
Price
$0.80
Change
-$0.04 (-4.76%)
Updated
Apr 3 closing price
Capitalization
48.78M
33 days until earnings call
ZLDAF
Price
$0.30
Change
+$0.01 (+3.45%)
Updated
Mar 13 closing price
Capitalization
3.59M
Ad is loading...

KRON vs ZLDAF

Header iconKRON vs ZLDAF Comparison
Open Charts KRON vs ZLDAFBanner chart's image
Kronos Bio
Price$0.80
Change-$0.04 (-4.76%)
Volume$108.84K
Capitalization48.78M
Zelira Therapeutics
Price$0.30
Change+$0.01 (+3.45%)
Volume$117
Capitalization3.59M
KRON vs ZLDAF Comparison Chart
Loading...
KRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRON vs. ZLDAF commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRON is a StrongBuy and ZLDAF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (KRON: $0.80 vs. ZLDAF: $0.30)
Brand notoriety: KRON and ZLDAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRON: 63% vs. ZLDAF: 50%
Market capitalization -- KRON: $48.78M vs. ZLDAF: $3.59M
KRON [@Biotechnology] is valued at $48.78M. ZLDAF’s [@Biotechnology] market capitalization is $3.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRON’s FA Score shows that 1 FA rating(s) are green whileZLDAF’s FA Score has 0 green FA rating(s).

  • KRON’s FA Score: 1 green, 4 red.
  • ZLDAF’s FA Score: 0 green, 5 red.
According to our system of comparison, ZLDAF is a better buy in the long-term than KRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRON’s TA Score shows that 4 TA indicator(s) are bullish.

  • KRON’s TA Score: 4 bullish, 4 bearish.

Price Growth

KRON (@Biotechnology) experienced а -3.03% price change this week, while ZLDAF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

KRON is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRON($48.8M) has a higher market cap than ZLDAF($3.59M). KRON YTD gains are higher at: -15.789 vs. ZLDAF (-21.723). ZLDAF has higher annual earnings (EBITDA): -3.17M vs. KRON (-80.84M). KRON has higher revenues than ZLDAF: KRON (9.86M) vs ZLDAF (40.9K).
KRONZLDAFKRON / ZLDAF
Capitalization48.8M3.59M1,359%
EBITDA-80.84M-3.17M2,550%
Gain YTD-15.789-21.72373%
P/E RatioN/AN/A-
Revenue9.86M40.9K24,117%
Total Cash125MN/A-
Total Debt25.8MN/A-
FUNDAMENTALS RATINGS
ZLDAF: Fundamental Ratings
ZLDAF
OUTLOOK RATING
1..100
35
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KRON
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 19 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
KRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OSPPX7.250.03
+0.40%
Invesco SteelPath MLP Alpha Plus R6
JISGX19.80N/A
N/A
JPMorgan Small Cap Growth L
VSIIX45.56N/A
N/A
Vanguard Small Cap Value Index I
HFDYX18.73N/A
N/A
Hartford Schroders US MidCap Opps Y
APITX11.80N/A
N/A
Yorktown Growth L

KRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRON has been loosely correlated with CYTK. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if KRON jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRON
1D Price
Change %
KRON100%
-4.31%
CYTK - KRON
42%
Loosely correlated
+0.67%
VERA - KRON
38%
Loosely correlated
-3.60%
AXON - KRON
38%
Loosely correlated
-3.35%
ARRY - KRON
37%
Loosely correlated
-10.32%
BTAI - KRON
36%
Loosely correlated
-8.54%
More

ZLDAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDAF has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDAF jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDAF
1D Price
Change %
ZLDAF100%
N/A
VSTM - ZLDAF
47%
Loosely correlated
-2.40%
QLGN - ZLDAF
28%
Poorly correlated
-2.93%
GNLX - ZLDAF
25%
Poorly correlated
-1.57%
SNSE - ZLDAF
22%
Poorly correlated
-11.12%
KRON - ZLDAF
20%
Poorly correlated
-4.31%
More